HOUSTON, May 5 /PRNewswire/ -- OrthoAccel Technologies, Inc. announced that it has entered into a partnership with AB Orthodontics, an Australian orthodontic supplies company, to introduce the AcceleDent System to the Australian market.
AcceleDent, an acceleration device to enhance orthodontics, was introduced to the United Kingdom last year. Results from the first clinical trial were recently highlighted in Orthodontic Practice US, a new industry publication. This study demonstrated increased rates of tooth movement as a result of using AcceleDent for 20 minutes daily. The device was also very well tolerated by study patients, who actually reported increasingly favorable satisfaction scores over the course of treatment.
Mike Kaufman, VP Marketing and Business Development at OrthoAccel noted the importance of the Australian market to the Company's strategic plans. "Attending the 7th International Orthodontic Congress earlier this year in Sydney provided us a first-hand opportunity to experience the Australian orthodontic market and meet many of the key opinion leaders. AB Orthodontics has a long and successful track record introducing innovative orthodontic products and with Andrew and his team we believe we have found the ideal long-term partner for the Australian and New Zealand markets."
OrthoAccel received TGA clearance late last year to commercialize AcceleDent in Australia, and attended the World Federation of Orthodontists 7th International Orthodontic Conference in Sydney earlier this year.
Andrew Binns, Managing Director of AB Orthodontics, who has been serving the Australian orthodontic market for over 30 years, commented, "AcceleDent represents an innovative opportunity for orthodontists to explore greater efficiencies through the possibility of faster case finishing, as well as truly position the practice as a full-service clinic with the latest treatment technology."
Earlier this month, AcceleDent was recognized with a Bronze Award at the 23rd Annual Excellence in Design competition, in the Medical, Laboratory, & Test Equipment category. Other winners included Philips Medical Respironics and Medtronic.
OrthoAccel is anticipating the conclusion of another US clinical trial at the UT Health Science Center in San Antonio with a target completion date later in 2010.
About OrthoAccel Technologies, Inc.
Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.
About AB Orthodontics Pty Ltd.
ABO was established in 1980 as an orthodontic supplies company serving the needs of the Australian orthodontic profession. Based in Melbourne, Australia, ABO is proud to offer the widest range of orthodontic materials of any company in the Asia-Pacific Region, and has an unrivalled dedication to delivering high quality service and competitive pricing to any orthodontic practice in Australia and New Zealand.
About the AcceleDent System
AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology. The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complementary with all existing orthodontic technologies. AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States. More information can be found at www.acceledent.com or requested via email@example.com
|SOURCE OrthoAccel Technologies, Inc.|
Copyright©2010 PR Newswire.
All rights reserved